Trial Outcomes & Findings for Physical Activity and Gastrointestinal Investigations (NCT NCT01507298)

NCT ID: NCT01507298

Last Updated: 2019-09-13

Results Overview

The primary outcome measure is amount of physical activity undertaken by participants throughout the study period. Participant motion data will be collected using a tri-axial accelerometer in the eAR sensor. Signal processing methods will be used to produce an activity index in the form of a numerical value, from the raw data. Activity levels were grouped at 1- minute intervals into restful, low, moderate or high intensity activity. Activity levels were calibrated for each participant, classifying activity into quartiles, where the most inactivity was labelled 'Restful', 2nd quartile 'low intensity', 3rd quartile 'moderate intensity' and upper quartile 'high intensity'. This provided a personalised activity profile with which to compare activity during the investigation.

Recruitment status

COMPLETED

Target enrollment

21 participants

Primary outcome timeframe

Difference between baseline (2 days average) and test day (during pH monitoring)

Results posted on

2019-09-13

Participant Flow

Participant milestones

Participant milestones
Measure
Capsule Endoscopy
A pill camera used for imaging the small bowel
24 Hour Oesophageal pH Study
Patients wore the accelerometer before and during the ambulatory oesophageal pH test for activity levels to be recorded and compared.
Overall Study
STARTED
1
20
Overall Study
COMPLETED
1
14
Overall Study
NOT COMPLETED
0
6

Reasons for withdrawal

Reasons for withdrawal
Measure
Capsule Endoscopy
A pill camera used for imaging the small bowel
24 Hour Oesophageal pH Study
Patients wore the accelerometer before and during the ambulatory oesophageal pH test for activity levels to be recorded and compared.
Overall Study
Protocol Violation
0
6

Baseline Characteristics

Physical Activity and Gastrointestinal Investigations

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Capsule Endoscopy
n=1 Participants
A pill camera used for imaging the small bowel
24 Hour Oesophageal pH Study
n=20 Participants
Patients wore the accelerometer before and during the ambulatory oesophageal pH test for activity levels to be recorded and compared.
Total
n=21 Participants
Total of all reporting groups
Age, Continuous
35 Years
STANDARD_DEVIATION 0 • n=5 Participants
53 Years
STANDARD_DEVIATION 11 • n=7 Participants
50 Years
STANDARD_DEVIATION 12 • n=5 Participants
Sex: Female, Male
Female
0 Participants
n=5 Participants
10 Participants
n=7 Participants
10 Participants
n=5 Participants
Sex: Female, Male
Male
1 Participants
n=5 Participants
10 Participants
n=7 Participants
11 Participants
n=5 Participants
Region of Enrollment
United Kingdom
1 participants
n=5 Participants
20 participants
n=7 Participants
21 participants
n=5 Participants

PRIMARY outcome

Timeframe: Difference between baseline (2 days average) and test day (during pH monitoring)

Population: Due to significant differences in expected and actual recruitment for the capsule endoscopy arm (i.e. 1 subject), raw data collected were not analysed to produce activity metrics.

The primary outcome measure is amount of physical activity undertaken by participants throughout the study period. Participant motion data will be collected using a tri-axial accelerometer in the eAR sensor. Signal processing methods will be used to produce an activity index in the form of a numerical value, from the raw data. Activity levels were grouped at 1- minute intervals into restful, low, moderate or high intensity activity. Activity levels were calibrated for each participant, classifying activity into quartiles, where the most inactivity was labelled 'Restful', 2nd quartile 'low intensity', 3rd quartile 'moderate intensity' and upper quartile 'high intensity'. This provided a personalised activity profile with which to compare activity during the investigation.

Outcome measures

Outcome measures
Measure
Capsule Endoscopy
A pill camera used for imaging the small bowel.
24 Hour Oesophageal pH Study
n=13 Participants
Patients wore the accelerometer before and during the ambulatory oesophageal pH test for activity levels to be recorded and compared.
Physical Activity Change (%)
-22 Percentage change in activity
Standard Deviation 20

SECONDARY outcome

Timeframe: Difference between baseline (2 days average) and test day (during pH monitoring)

Population: Raw data captured for capsule endoscopy group not analysed to produce activity metrics due to insufficient numbers recruited (i.e. 1 subject).

Measuring the changes in restful (activity equivalent to sitting), low (activity equivalent to a slow walk), moderate (activity equivalent to a brisk walk) and high intensity activity (activity equivalent to running). Including subject-specific activity intensity quartiles, were calculated and compared.

Outcome measures

Outcome measures
Measure
Capsule Endoscopy
A pill camera used for imaging the small bowel.
24 Hour Oesophageal pH Study
n=13 Participants
Patients wore the accelerometer before and during the ambulatory oesophageal pH test for activity levels to be recorded and compared.
Change in Relative Intensity of Daily Activities (%)
Restful
8.5 Percentage change in activity
Standard Deviation 17
Change in Relative Intensity of Daily Activities (%)
Low
-1 Percentage change in activity
Standard Deviation 24
Change in Relative Intensity of Daily Activities (%)
Moderate
-1 Percentage change in activity
Standard Deviation 24
Change in Relative Intensity of Daily Activities (%)
High
-6 Percentage change in activity
Standard Deviation 7

Adverse Events

Capsule Endoscopy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

24 Hour Oesophageal pH Study

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Richard Mark Kwasnicki

Imperial College London

Phone: 07851759471

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place